Quantcast

Latest AstraZeneca Stories

2014-02-05 00:20:33

BASEL, Switzerland, Feb. 5, 2014 /PRNewswire/ -- On track to meet growth objectives -- Sales $14.7 billion, up 3 percent; up 5 percent at constant exchange rates -- Integrated sales up 6 percent(1) -- underlying growth excluding corn rootworm royalty 8 percent(1) -- EBITDA $2.9 billion: 7 percent lower -- lower royalty income, non-recurring seeds costs -- Earnings per share(2) $19.30: 12 percent lower -- Proposed dividend increased by 5...

2014-02-03 12:27:27

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Biologics and Biosimilars World Markets Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating conditions such as cancer and autoimmunity. Also known as follow-on biologics or subsequent entry biologics (SEBs), biosimilars are to biologics...

2014-02-03 12:26:49

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Inflammation Global Clinical Trials Review, H2, 2013 Inflammation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, "Inflammation Global Clinical Trials Review, H2, 2013" provides data on the Inflammation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammation. It includes an...

2014-01-30 08:32:21

AVP-825 uses novel Breath Powered(TM) drug delivery to treat migraine YARDLEY, Pa., Jan. 30, 2014 /PRNewswire/ -- A New Drug Application (NDA) was submitted on Monday January 27, 2014 to the U.S. Food and Drug Administration for AVP-825, a product using OptiNose's innovative closed-palate Breath Powered intranasal delivery system to deliver low-dose sumatriptan powder for the acute treatment of migraine. The NDA submission is based on a series of laboratory and clinical studies...

2014-01-29 08:30:15

SAN DIEGO, Jan. 29, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced that it has performed its first 3D Liver tissue delivery. The achievement marks the delivery of Organovo's 3D Liver tissue to a laboratory outside of the company to a key opinion leader (KOL) for experimentation, and marks the achievement of a milestone along the pathway to commercial...

2014-01-29 08:29:27

- Preclinical development completed for H7N9 vaccine candidates that addresses significant unmet medical need - BEIJING, Jan. 29, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration (CFDA) to commence human clinical trials for its vaccine against Avian influenza A(H7N9) virus. The CTA was officially accepted...

2014-01-29 00:20:55

SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that their influenza vaccine (gH1-Qbeta) met its primary end point for immunogenicity (seroconversion based on haemaglutination inhibition titres according to FDA criteria) in the Phase 1 clinical trial in healthy Asian volunteers. The induced immune response showed good cross-reactivity to recent...

2014-01-27 16:24:34

DUBLIN, Ireland, January 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7dmdjw/market_for_select) has announced the addition of the "2014 Report on Select Cardiovascular Drugs in the GCC Region" [http://www.researchandmarkets.com/research/7dmdjw/market_for_select ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The local governments are increasingly focusing on improving the health...

2014-01-23 04:21:26

LONDON and BOSTON, January 23, 2014 /PRNewswire/ -- Stabilised GPCR (StaR(R)) Proteins Delivered For All Nominated Targets Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, has successfully completed the research phase of its antibody drug discovery collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. In achieving this milestone, Heptares has delivered StaR(R) proteins...

2014-01-21 23:27:11

“2014 Deep Research Report on Global and China Propofol Industry” and “2014 Deep Research Report on Global And China Nucleotide Industry” are the new research reports added to the online library of DeepResearchReports.com. Dallas, Texas (PRWEB) January 21, 2014 2014 Deep Research Report on Global And China Nucleotide Industry is a professional and in-depth study on the current state of the nucleotide industry in Global and China. The report provides a basic overview of the...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related